BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30989655)

  • 1. REBACIN® as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection.
    Yang Y; Meng YL; Duan SM; Zhan SB; Guan RL; Yue TF; Kong LH; Zhou L; Deng LH; Huang C; Wang S; Wang GY; Wu DF; Zhang CF; Chen F
    Int J Cancer; 2019 Nov; 145(10):2712-2719. PubMed ID: 30989655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REBACIN® is an optional intervention for persistent high-risk human papillomavirus infection: A retrospective analysis of 364 patients.
    Yang Y; Hu T; Ming X; Yang E; Min W; Li Z
    Int J Gynaecol Obstet; 2021 Jan; 152(1):82-87. PubMed ID: 32966600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REBACIN
    Zhou SG; Wu DF; Yao H; Zhang WY; Tian FJ; Chen G; Zhang CF
    Front Oncol; 2022; 12():1047222. PubMed ID: 36561517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Noninvasive Clinical Intervention of REBACIN® on Histologic Regression of High Grade Cervical Intraepithelial Neoplasia.
    Wang F; Liu R; Ma Y; Wu DF; Deng LH; Wang S; Wang GY; Zhang CF; Qu QX
    Front Med (Lausanne); 2021; 8():627355. PubMed ID: 34355000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
    Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
    Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: A real-world prospective multicenter cohort study.
    Chen F; Zhang GN; Lei W; Zhou SG; Zhang Y; Liu L; Jia Y; Xie RK; Tian XF; Guo J; Yang YB; Wang XF; Wu XM; Sun QJ; Zhou X; Lin Y; Zhang YZ; Ma JQ; Liu YX; Cheng YF; Chen JC; Qu QX; Du DM; Wang GY; Wang S; Ling YL; Wu DF; Zhang CF; Lang JH
    Gynecol Oncol; 2023 Nov; 178():8-13. PubMed ID: 37734188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
    Han F; Li Y; Lu Q; Ma L; Wang H; Jiang J; Li Z; Li Y
    Virol J; 2017 Jul; 14(1):145. PubMed ID: 28754129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
    Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
    Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
    BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses].
    Yugawa T; Kiyono T
    Uirusu; 2008 Dec; 58(2):141-54. PubMed ID: 19374192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
    Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins.
    Almeida AM; Queiroz JA; Sousa F; Sousa Â
    Drug Discov Today; 2019 Oct; 24(10):2044-2057. PubMed ID: 31398400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL; Qiu XH; Shen C; Liu JN; Zhang J
    Oncol Rep; 2010 Nov; 24(5):1323-9. PubMed ID: 20878127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-linked-N-acetylglucosamine transferase is associated with metastatic spread of human papillomavirus E6 and E7 oncoproteins to the lungs of mice.
    Kim SH; Kim YS; Choi MY; Kim M; Yang JH; Park HO; Jang IS; Moon SH; Kim HO; Song DH; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi JY; Choi WS
    Biochem Biophys Res Commun; 2017 Feb; 483(2):793-802. PubMed ID: 27845045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
    Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
    Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
    Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.